These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20442726)

  • 1. Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
    Alakurtti K; Aalto S; Johansson JJ; Någren K; Tuokkola T; Oikonen V; Laine M; Rinne JO
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):155-65. PubMed ID: 20442726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
    Hirvonen J; Aalto S; Lumme V; Någren K; Kajander J; Vilkman H; Hagelberg N; Oikonen V; Hietala J
    Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.
    Alakurtti K; Johansson JJ; Joutsa J; Laine M; Bäckman L; Nyberg L; Rinne JO
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1199-205. PubMed ID: 25853904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.
    Kodaka F; Ito H; Kimura Y; Fujie S; Takano H; Fujiwara H; Sasaki T; Nakayama K; Halldin C; Farde L; Suhara T
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):574-9. PubMed ID: 23238524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between subcortical brain volume and striatal dopamine D
    Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
    Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High long-term test-retest reliability for extrastriatal
    Karalija N; Jonassson L; Johansson J; Papenberg G; Salami A; Andersson M; Riklund K; Nyberg L; Boraxbekk CJ
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1859-1868. PubMed ID: 31506011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A
    Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.
    Mawlawi O; Martinez D; Slifstein M; Broft A; Chatterjee R; Hwang DR; Huang Y; Simpson N; Ngo K; Van Heertum R; Laruelle M
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1034-57. PubMed ID: 11524609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatum.
    Rousset OG; Collins DL; Rahmim A; Wong DF
    J Nucl Med; 2008 Jul; 49(7):1097-106. PubMed ID: 18552147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.
    Catafau AM; Suarez M; Bullich S; Llop J; Nucci G; Gunn RN; Brittain C; Laruelle M;
    Neuroimage; 2009 Jun; 46(2):447-58. PubMed ID: 19233294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.
    Penttilä J; Kajander J; Aalto S; Hirvonen J; Någren K; Ilonen T; Syvälahti E; Hietala J
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):431-9. PubMed ID: 15315717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
    Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.